Desenex Ointment
Natural health product licensed in Canada
- Licence holder
- Haleon Canada ULC
- NPN or DIN-HM
- 02021919
- Status
- Inactive licence
- Licence date
- 13 February 2008
- Revision date
- Not provided
- Form
- Onguent
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| acide undécylénique | 5.4 % |
| Undécylénate de zinc | 20 % |
Non-medicinal ingredients
Polyoxyethylene laurate, Pétrolatum, Acide stéarique, Glycol Stearate, Lanoline, triéthanolamine, Parahydroxybenzoate de méthyle, Sorbitol, Eau, Polyethylene Glycol Stearate, Parfum
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | 2 Tous les jours |
| Enfants | minimum: 2 years | Not specified | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Kills athlete's foot fungus, jock itch or ringworm fungus. Relieves itching, burning, crackling and irritation of athlete's foot, jack itch or ringworm.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
N/A
- Effets indésirables connus
N/A
Source
Official Health Canada record, licence 02021919
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.